We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYAI icon
2876
Dyadic International
DYAI
$28.3M
$140K ﹤0.01%
18,500
+17,399
+1,580% +$144K
LAKE icon
2877
Lakeland Industries
LAKE
$119M
$140K ﹤0.01%
7,078
+5,034
+246% +$110K
VRA icon
2878
Vera Bradley
VRA
$94.4M
$140K ﹤0.01%
22,971
+18,549
+419% +$99K
INDT
2879
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$140K ﹤0.01%
2,620
-861
-25% -$45.3K
FMTX
2880
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$140K ﹤0.01%
2,805
+2,609
+1,331% +$105K
CXO
2881
DELISTED
CONCHO RESOURCES INC.
CXO
$140K ﹤0.01%
3,170
-16,327
-84% -$814K
ALTG icon
2882
Alta Equipment Group
ALTG
$233M
$139K ﹤0.01%
17,696
+16,853
+1,999% +$134K
BCML icon
2883
BayCom
BCML
$340M
$139K ﹤0.01%
13,489
+10,379
+334% +$119K
BWA icon
2884
BorgWarner
BWA
$13.9B
$139K ﹤0.01%
4,067
-7,358
-64% -$253K
CRD.A icon
2885
Crawford & Co Class A
CRD.A
$623M
$139K ﹤0.01%
21,232
+16,030
+308% +$119K
HBI
2886
DELISTED
Hanesbrands
HBI
$139K ﹤0.01%
8,842
+540
+7% +$7.93K
IMVT icon
2887
Immunovant
IMVT
$8.49B
$139K ﹤0.01%
3,946
+2,891
+274% +$87K
OXY icon
2888
Occidental Petroleum
OXY
$58.6B
$139K ﹤0.01%
13,886
-14,096
-50% -$199K
PFBC icon
2889
Preferred Bank
PFBC
$1.28B
$139K ﹤0.01%
4,329
+2,503
+137% +$93.5K
QUAD icon
2890
Quad
QUAD
$503M
$139K ﹤0.01%
45,673
+34,860
+322% +$115K
BITA
2891
DELISTED
Bitauto Holdings Limited
BITA
$139K ﹤0.01%
8,820
+4,628
+110% +$73.1K
GNE icon
2892
Genie Energy
GNE
$384M
$138K ﹤0.01%
17,290
+12,952
+299% +$109K
NGVC icon
2893
Vitamin Cottage Natural Grocers
NGVC
$640M
$138K ﹤0.01%
13,984
+8,478
+154% +$111K
PB icon
2894
Prosperity Bancshares
PB
$9B
$138K ﹤0.01%
2,667
-9,165
-77% -$502K
PKBK icon
2895
Parke Bancorp
PKBK
$416M
$138K ﹤0.01%
11,584
+9,086
+364% +$114K
ARES icon
2896
Ares Management
ARES
$33B
$137K ﹤0.01%
3,409
-5,831
-63% -$233K
CABA icon
2897
Cabaletta Bio
CABA
$435M
$137K ﹤0.01%
12,633
+7,911
+168% +$90.9K
GAIA icon
2898
Gaia
GAIA
$35.3M
$137K ﹤0.01%
13,856
+9,083
+190% +$94K
GFI icon
2899
Gold Fields
GFI
$35.7B
$137K ﹤0.01%
11,105
-10,098
-48% -$124K
MPB icon
2900
Mid Penn Bancorp
MPB
$974M
$136K ﹤0.01%
7,884
+6,434
+444% +$123K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.